全文获取类型
收费全文 | 26766篇 |
免费 | 1530篇 |
国内免费 | 629篇 |
专业分类
耳鼻咽喉 | 168篇 |
儿科学 | 1722篇 |
妇产科学 | 1459篇 |
基础医学 | 3110篇 |
口腔科学 | 416篇 |
临床医学 | 1787篇 |
内科学 | 3965篇 |
皮肤病学 | 266篇 |
神经病学 | 2550篇 |
特种医学 | 376篇 |
外国民族医学 | 3篇 |
外科学 | 3268篇 |
综合类 | 3353篇 |
现状与发展 | 4篇 |
预防医学 | 1792篇 |
眼科学 | 123篇 |
药学 | 2478篇 |
12篇 | |
中国医学 | 861篇 |
肿瘤学 | 1212篇 |
出版年
2023年 | 214篇 |
2022年 | 401篇 |
2021年 | 712篇 |
2020年 | 633篇 |
2019年 | 599篇 |
2018年 | 616篇 |
2017年 | 707篇 |
2016年 | 745篇 |
2015年 | 760篇 |
2014年 | 1292篇 |
2013年 | 1771篇 |
2012年 | 1232篇 |
2011年 | 1506篇 |
2010年 | 1227篇 |
2009年 | 1160篇 |
2008年 | 1265篇 |
2007年 | 1275篇 |
2006年 | 1241篇 |
2005年 | 1077篇 |
2004年 | 896篇 |
2003年 | 857篇 |
2002年 | 745篇 |
2001年 | 676篇 |
2000年 | 641篇 |
1999年 | 506篇 |
1998年 | 415篇 |
1997年 | 434篇 |
1996年 | 418篇 |
1995年 | 408篇 |
1994年 | 402篇 |
1993年 | 347篇 |
1992年 | 345篇 |
1991年 | 345篇 |
1990年 | 349篇 |
1989年 | 280篇 |
1988年 | 228篇 |
1987年 | 201篇 |
1986年 | 219篇 |
1985年 | 283篇 |
1984年 | 249篇 |
1983年 | 149篇 |
1982年 | 194篇 |
1981年 | 163篇 |
1980年 | 137篇 |
1979年 | 122篇 |
1978年 | 107篇 |
1977年 | 94篇 |
1976年 | 70篇 |
1975年 | 50篇 |
1973年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 探究影响我国老年人认知水平的变化趋势,分离出年龄、队列效应。方法 基于CLHLS(2002—2018)多重队列追踪数据,以Stata16.0软件为工具,运用分层生长曲线模型进行统计分析。结果 本研究发现,个体行为生活方式、社会经济地位、性别、慢性病数量对认知水平均具有统计学意义;年龄、队列对认知水平的变化具有独立效应;随着年龄的增长,我国老年人认知水平下降,认知水平的城乡、性别差异明显;较年轻出生队列的老年人认知水平较好,认知水平的城乡差异随着队列的年轻化而变大,性别差异在较年轻队列有略微缩小的趋势。结论 影响认知水平因素复杂,认知障碍会增加医疗成本及照护负担,因此需准确把握老年认知水平的变化规律与作用路径,从而为卫生服务、养老保障、长期医疗照护的资源配置提供科学依据。 相似文献
2.
目的 探讨精神科护士夜班经历创伤事件后的成长体验,以期为护士不同阶段心理情况进行针对性干预和指导,并为护士职业生涯早期心理建设提供方向。方法 采用扎根理论的研究方法,2020年3月—7月对广东省某三级甲等医院12名夜班经历创伤事件的精神科护士进行深度访谈,采用Strauss和Corbin扎根理论分析资料,分为开放式登录、轴心式登录和选择式登录3个阶段,持续比较分析资料。结果 发现精神科护士夜班经历创伤事件后经历了应激期、调适期、成长期3个不同阶段。结论 精神科护士夜班经历创伤事件后的成长为动态过程,管理者或干预者可根据不同阶段进行针对性干预和指导,并在护士早期培训中促使其提前做好相关知识、技能的储备和必备心理素质的塑造。 相似文献
3.
Laura A. Huppert MD Ozge Gumusay MD Dame Idossa MD Hope S. Rugo MD 《CA: a cancer journal for clinicians》2023,73(5):480-515
Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is defined by the presence of the estrogen receptor and/or the progesterone receptor and the absence of HER2 gene amplification. HR-positive/HER2-negative breast cancer accounts for 65%–70% of all breast cancers, and incidence increases with increasing age. Treatment varies by stage, and endocrine therapy is the mainstay of treatment in both early stage and late-stage disease. Combinations with cyclin-dependent kinase 4/6 inhibitors have reduced distant recurrence in the early stage setting and improved overall survival in the metastatic setting. Chemotherapy is used based on stage and tumor biology in the early stage setting and after endocrine resistance for advanced disease. New therapies, including novel endocrine agents and antibody-drug conjugates, are now changing the treatment landscape. With the availability of new treatment options, it is important to define the optimal sequence of treatment to maximize clinical benefit while minimizing toxicity. In this review, the authors first discuss the pathologic and molecular features of HR-positive/HER2-negative breast cancer and mechanisms of endocrine resistance. Then, they discuss current and emerging therapies for both early stage and metastatic HR-positive/HER2-negative breast cancer, including treatment algorithms based on current data. 相似文献
4.
目的观察脐带间充质干细胞分泌的外泌体对骨性关节炎模型大鼠疼痛行为、软骨修复及背根神经节(DRG)中转录激活因子3(ATF-3)及生长相关蛋白43(GAP-43)表达的影响, 并探讨外泌体治疗关节炎疼痛的可能机制。方法采用随机数字表法将54只雄性SD大鼠分为假手术组、模型组和外泌体组, 每组18只, 除假手术组外, 其余2组均于左后肢膝关节腔注射4 mg/50 μl单碘乙酸钠(MIA)建立疼痛模型, 假手术组大鼠关节腔注射50 μl生理盐水作为对照。造模14天后, 假手术组和模型组大鼠左后肢膝关节腔注射50 μl生理盐水, 外泌体组大鼠注射50 μl外泌体。于造模前1天、造模后第7、14天及给药后第7、14、28天对各组大鼠机械痛阈和热痛阈进行测定;于测试后取出相应时间点DRG, 采用免疫蛋白印迹法检测ATF-3及GAP-43表达情况;并取出相应时间点各组大鼠膝关节, 采用苏木素伊红(HE)染色检测软骨修复情况。结果与模型组比较, 外泌体组在给药后第7天时, 机械痛阈值及热痛阈值均明显增加, 直到给药后第28天时差异均具有统计学意义(P<0.05);DRG水平ATF-3蛋白表达显著... 相似文献
5.
6.
7.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献
8.
《Saudi Dental Journal》2022,34(3):194-201
Dental sleep medicine is the field of dental practice that deals with the management of sleep-related breathing disorders, which includes obstructive sleep apnea (OSA) in adults and children. Depending on the developmental age of the patient and the cause of the apnea dental treatment options may vary. For adult patients, treatment modalities may include oral appliance therapy (OAT), orthognathic surgery and surgical or miniscrew supported palatal expansion. While for children, treatment may include non-surgical maxillary expansion and orthodontic functional appliances. Many physicians and dentists are unaware of the role dentistry, particularly orthodontics, may play in the interdisciplinary management of these disorders. This review article is an attempt to compile evidence-based relevant information on the role of orthodontists/sleep dentists in the screening, diagnosis, and management of sleep apnea. Oral sleep appliance mechanisms of action, selective efficacy, and the medical physiological outcomes are discussed. The purpose of this review is to provide a comprehensive understanding of how orthodontists and sleep physicians can work in tandem to maximize the benefits and minimize the side effects while treating patients with OSA. 相似文献
9.
10.